[Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
Tfelt-Hansen
Peer
P
Dansk Hovedpinecenter, Amtssygehuset i Glostrup, Neurologisk Afdeling, Glostrup. tfelt@inet.uni2.dk
Iversen
Helle K
HK
D000208:Acute Disease; D000284:Administration, Oral; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D011759:Pyrrolidines / Q000008:administration & dosage*; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D018170:Sumatriptan / Q000008:administration & dosage*; D014230:Triazoles / Q000008:administration & dosage*; D014363:Tryptamines / Q000008:administration & dosage*
D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C115647:eletriptan; C093622:rizatriptan; D018170:Sumatriptan